caa a22 4500 477072364 CHVBK 20180405111429.0 cr unu---uuuuu 170330e19960901xx s 000 0 eng 10.1007/BF00051103 doi (NATIONALLICENCE)springer-10.1007/BF00051103 Calcium channel antagonists in the modern era of coronary thrombolysis: Benefit or detriment? [Elektronische Daten] [John Foley, Richard Becker] Summary: Calcium channel antagonists are among the world's most widely prescribed class of drugs and are used most often in patients with hypertension and coronary artery disease. However, in the recent past serious questions have been raised concerning their potentially detrimental effects. One area of considerable clinical importance that deserves close inspection is the role of calcium channel antagonists following coronary reperfusion. Specifically, is there benefit or detriment? Kluwer Academic Publishers, 1996 calcium channel antagonists nationallicence thrombolysis nationallicence hemorrhage nationallicence complications nationallicence Foley John Cardiovascular Thrombosis Research Center, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA aut Becker Richard Cardiovascular Thrombosis Research Center, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA aut Cardiovascular Drugs and Therapy Kluwer Academic Publishers 10/4(1996-09-01), 403-407 0920-3206 10:4<403 1996 10 10557 https://doi.org/10.1007/BF00051103 text/html Onlinezugriff via DOI 1 editorial jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF00051103 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Foley John Cardiovascular Thrombosis Research Center, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA aut NATIONALLICENCE 700 1- Becker Richard Cardiovascular Thrombosis Research Center, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA aut NATIONALLICENCE 773 0- Cardiovascular Drugs and Therapy Kluwer Academic Publishers 10/4(1996-09-01), 403-407 0920-3206 10:4<403 1996 10 10557 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer